Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma

		Keywords:		Tandutinib

		Phase:		Phase 1/2

		Treatment ID#s:		VT1766 NCT00379080

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Newly Diagnosed: N Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		04/21/2009

		Tumor Types:		Glioblastoma Multiforme


		Comments:		RATIONALE: Tandutinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.

		Treatment Type:		Less-Toxics Immunological, Biological or Targeted Therapy.

		Contact:		Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham Clinical Trials Office - University of Alabama at Birmingham Birmingham, AL 35294 Phone:205-934-0309 Email not available Emory University Jeffrey Olsen Contact: Dr. Jeffrey Olsen 1327 Clifton Road, NE Atlanta, GA 30322- Phone:(404)778-5344 Fax: (404)778-5121 Click here to send an email Mass. General Hospital - Brain Tumor Center Tracy Batchelor, MD, MPH Executive Director Brain Tumor Center Suite 315, Cox Building Boston, MA 02114 Phone:617-724-8770 Fax: (617)724-8769 Click here to send an email Website: brain.mgh.harvard.edu Johns Hopkins Hospital Stuart Grossman, MD Professor of Oncology, Medicine & Neurosurgery Contact: Stuart Grossman Bunting & Blaustein Cancer Research Bldg 1650 Orleans Street Baltimore, MD 21231-1000 Phone:(410)955-8837 Fax: 410-614-9335 Click here to send an email Website: www.nabtt.org/johns.html National Cancer Institute NCI Cheryl Royce, CRNP, Clinical Director Neuro-oncology Branch 9030 Old Georgetown Road Bethesda, MD 20892 Phone:866-251-9686 Click here to send an email Website: home.ccr.cancer.gov/nob/ Henry Ford Hospital Tom MikKelsen, MD, FRCP(C) Co-Director Contact: Dr. Tom Mikelsen Hermelin Brain Tumor Center E&R3096 Henry Ford Hospital 2799 West Grand Blvd Detroit, MI 48202- Phone:313 916-8641 Fax: 313 916-9855 Click here to send an email Website: www.henryfordhealth.org/body.cfm?id=38441&action=detail&ref=968 Wake Forest Comprehensive Cancer Center Judy Lovelace, R.N. Medical Oncology Medical Center Blvd. Winston-Salem, NC 27157 Phone:336-716-6759 Fax: ( ) - Click here to send an email Website: www.bgsm.edu/bgsm/surg-sci/ns/btprotocols.html Cleveland Clinic Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center Gene Barnett, MD : Professor and Director, Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center Cleveland, OH 44195 Phone:216-445-1379 Fax: 216-444-0924 Click here to send an email Website: my.clevelandclinic.org/brain_tumor/default.aspx Hospital of the Univ. of PA Steven Brem, MD 3 Silverstein 3400 Spruce Street Philadelphia, PA 19104 Phone:1-800-789-PENN (7366) Email not available Website: www.pennmedicine.org/wagform/MainPage.aspx?config=provider&P=PP&ID=13149 Abramson Cancer Center Clinical Trials Office - Abramson Cancer Center University of Pennsylvania Philadelphia, PA 19104 Phone:800-474-9892 Email not available